Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis

Fingolimod is a selective immunosuppressive agent approved worldwide for the treatment of relapsing-remitting multiple sclerosis (MS), a chronic and potentially disabling neurological condition. Randomized double-blind clinical trials have shown that fingolimod significantly reduces relapse rate and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Healthc Patient Saf
Hoofdauteurs: Gajofatto, Alberto, Turatti, Marco, Monaco, Salvatore, Benedetti, Maria Donata
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2015
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4686225/
https://ncbi.nlm.nih.gov/pubmed/26715860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S69640
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items